South African-based JSE Limited listed Aspen is a supplier of branded and generic pharmaceuticals in approximately 100 countries across the globe and of consumer and nutritional products in selected territories.
Aspen is represented in South Africa, Australia, Hong Kong, Kenya, Tanzania, Uganda, Dubai, Germany, Ireland, Mauritius, Brazil, Mexico and Venezuela. The Group has 18 manufacturing facilities at 13 sites on 5 continents.
Aspen has production capabilities for a wide variety of product types including tablets, capsules, steriles, injectables, oral contraceptives, nutritional products, lyophilised vials, cytotoxics, suppositories, vials, form-filled seals, liquids, semi-solids and specialist active pharmaceutical ingredients.
Aspen Generics
Which one's the generic?
South Africa's generic
brand of choice.
Investor Relations
Aspen financial year ended 30 June 2011:
Results presentation - click here (7.49Mb)
Aspen 2011 Annual Report - click here for link; click here for pdf (6.4 Mb)
Reviewed preliminary results - click here (773 Kb)
Nagegane voorlopige resultate - sien hier (784 Kb)
Reviewed preliminary results booklet - click here (1.1 Mb)
Interim results for the six months ended 31 December 2010 - click here